The axo-myelinic synapse

Trends in Neurosciences

Volumn 34, Issue 8, 2011, Pages 393-400

  Stys, Peter K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; NEUROTRANSMITTER;

CELL METABOLISM; HUMAN; MYELIN SHEATH; MYELINATION; NERVE FIBER; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; PRIORITY JOURNAL; REVIEW; SYNAPSE;

ANIMALS; AXONS; DEMYELINATING DISEASES; HUMANS; MYELIN SHEATH; RECEPTORS, NEUROTRANSMITTER; SYNAPSES;

EID: 79960937024     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2011.06.004     Document Type: Review

References (113)

1. Rushton W.A.H. A theory of the effects of fibre size in medullated nerve. J. Physiol. 1951, 115:101-122.
2. Hodgkin A.L. A note on conduction velocity. J. Physiol. 1954, 125:221-224.
3. Hartline D.K., Colman D.R. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr. Biol. 2007, 17:R29-35.
4. Barrett E.F., Barrett J.N. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J. Physiol. 1982, 323:117-144.
5. Blight A.R., Someya S. Depolarizing afterpotentials in myelinated axons of mammalian spinal cord. Neuroscience 1985, 15:1-12.
6. Nave K.A. Myelination and support of axonal integrity by glia. Nature 2010, 468:244-252.
7. Ritchie J.M. On the relation between fibre diameter and conduction velocity in myelinated nerve fibres. Proc. R. Soc. Lond. B Biol. Sci. 1982, 217:29-35.
8. Michailov G.V., et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 2004, 304:700-703.
9. Franklin R.J., ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
10. Emery B. Regulation of oligodendrocyte differentiation and myelination. Science 2010, 330:779-782.
11. Barres B.A., Raff M.C. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature 1993, 361:258-260.
12. Demerens C., et al. Induction of myelination in the central nervous system by electrical activity. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:9887-9892.
13. Stevens B., et al. Control of myelination by specific patterns of neural impulses. J. Neurosci. 1998, 18:9303-9311.
14. Ishibashi T., et al. Astrocytes promote myelination in response to electrical impulses. Neuron 2006, 49:823-832.
15. Stevens B., Fields R.D. Response of Schwann cells to action potentials in development. Science 2000, 287:2267-2271.
16. Fields R.D., Burnstock G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 2006, 7:423-436.
17. Debanne D., et al. Axon physiology. Physiol. Rev. 2011, 91:555-602.
18. Nakagawa S., et al. Structural and functional studies of gap junction channels. Curr. Opin. Struct. Biol. 2010, 20:423-430.
19. Kirischuk S., et al. Activation of P2-purinoreceptors triggered Ca2+ release from InsP3-sensitive internal stores in mammalian oligodendrocytes. J. Physiol. 1995, 483:41-57.
20. Kettenmann H., Steinhauser C. Receptors for neurotransmitters and hormones. Neuroglia 2005, 131-145. Oxford University Press. 2nd edn. H. Kettenmann, B.R. Ransom (Eds.).
21. Verkhratsky A., Kirchhoff F. NMDA receptors in glia. Neuroscientist 2007, 13:28-37.
22. Verkhratsky A., et al. Purinoceptors on neuroglia. Mol. Neurobiol. 2009, 39:190-208.
23. Bakiri Y., et al. Glutamatergic signaling in the brain's white matter. Neuroscience 2009, 158:266-274.
24. Matute C. Glutamate and ATP signalling in white matter pathology. J. Anat. 2011, 219:53-64.
25. Li S., Stys P.K. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J. Neurosci. 2000, 20:1190-1198.
26. Brand-Schieber E., Werner P. AMPA/kainate receptors in mouse spinal cord: cell-specific display of receptor subunits by oligodendrocytes and astrocytes and at the nodes of Ranvier. Glia 2003, 42:12-24.
27. Brand-Schieber E., Werner P. (+/-)-Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and kainate receptor subunit expression in mouse versus rat spinal cord white matter: similarities in astrocytes but differences in oligodendrocytes. Neurosci. Lett. 2003, 345:126-130.
28. Karadottir R., et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005, 438:1162-1166.
29. Micu I., et al. NMDA receptors mediate Ca accumulation in central nervous system myelin during chemical ischemia. Nature 2006, 439:988-992.
30. Salter M.G., Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005, 438:1167-1171.
31. Micu I., et al. Real-time measurement of free Ca2+ changes in CNS myelin by two-photon microscopy. Nat. Med. 2007, 13:874-879.
32. Piña-Crespo J.C., et al. Excitatory glycine responses of CNS myelin mediated by NR1/NR3 'NMDA' receptor subunits. J. Neurosci. 2010, 30:11501-11505.
33. Chatterton J.E., et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 2002, 415:793-798.
34. Smothers C.T., Woodward J.J. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits. J. Pharmacol. Exp. Ther. 2007, 322:739-748.
35. Henson M.A., et al. Influence of the NR3A subunit on NMDA receptor functions. Prog. Neurobiol. 2010, 91:23-37.
36. Low C.M., Wee K.S. New insights into the not-so-new NR3 subunits of N-methyl-D-aspartate receptor: localization, structure, and function. Mol. Pharmacol. 2010, 78:1-11.
37. Butt A.M. Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology. Glia 2006, 54:666-675.
38. James G., Butt A.M. P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system. Eur. J. Pharmacol. 2002, 447:247-260.
39. Matute C., et al. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. 2007, 27:9525-9533.
40. Domercq M., et al. P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 2010, 58:730-740.
41. Debruin L.S., Harauz G. White matter rafting: membrane microdomains in myelin. Neurochem. Res. 2007, 32:213-228.
42. Alix J.J., Fern R. Glutamate receptor-mediated ischemic injury of premyelinated central axons. Ann. Neurol. 2009, 66:682-693.
43. Ouardouz M., et al. Complex interplay between glutamate receptors and intracellular Ca2+ stores during ischaemia in rat spinal cord white matter. J. Physiol. 2006, 577:191-204.
44. Ouardouz M., et al. Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann. Neurol. 2009, 65:151-159.
45. Ouardouz M., et al. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann. Neurol. 2009, 65:160-166.
46. Stirling D.P., Stys P.K. Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol. Med. 2010, 16:160-170.
47. Villegas J. Axon-Schwann cell interaction in the squid nerve fibre. J. Physiol. 1972, 225:275-296.
48. Chiu S.Y., Kriegler S. Neurotransmitter-mediated signaling between axons and glial cells. Glia 1994, 11:191-200.
49. Kriegler S., Chiu S.Y. Calcium signaling of glial cells along mammalian axons. J. Neurosci. 1993, 13:4229-4245.
50. Bergles D.E., et al. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 2000, 405:187-191.
51. Lin S.C., Bergles D.E. Synaptic signaling between neurons and glia. Glia 2004, 47:290-298.
52. Bergles D.E., et al. Neuron-glia synapses in the brain. Brain Res. Rev. 2010, 63:130-137.
53. Kukley M., et al. Vesicular glutamate release from axons in white matter. Nat. Neurosci. 2007, 10:311-320.
54. Ziskin J.L., et al. Vesicular release of glutamate from unmyelinated axons in white matter. Nat. Neurosci. 2007, 10:321-330.
55. Hamilton N., et al. Axons and astrocytes release ATP and glutamate to evoke calcium signals in NG2-glia. Glia 2010, 58:66-79.
56. Alix J.J., et al. Vesicular apparatus, including functional calcium channels, are present in developing rodent optic nerve axons and are required for normal node of Ranvier formation. J. Physiol. 2008, 586:4069-4089.
57. Arranz A.M., et al. Functional glutamate transport in rodent optic nerve axons and glia. Glia 2008, 56:1353-1367.
58. Li S., et al. Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport. J. Neurosci. 1999, 19:RC16.
59. Nikolaeva M.A., et al. Effects of the noradrenergic system in rat white matter exposed to oxygen-glucose deprivation in vitro. J. Neurosci. 2009, 29:1796-1804.
60. Fern R., Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J. Neurosci. 2000, 20:34-42.
61. Attwell D., et al. Nonvesicular release of neurotransmitter. Neuron 1993, 11:401-407.
62. David G., et al. Electrical and morphological factors influencing the depolarizing after-potential in rat and lizard myelinated axons. J. Physiol. 1995, 489:141-157.
63. Stys P.K., et al. Intracellular concentrations of major ions in rat myelinated axons and glia: calculations based on electron probe X-ray microanalyses. J. Neurochem. 1997, 68:1920-1928.
64. Blaurock A.E. The spaces between membrane bilayers within PNS myelin as characterized by X-ray diffraction. Brain Res. 1981, 210:383-387.
65. Ropte S., et al. The intermediate dense line of the myelin sheath is preferentially accessible to cations and is stabilized by cations. J. Neurocytol. 1990, 19:242-252.
66. Ishii A., et al. Human myelin proteome and comparative analysis with mouse myelin. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14605-14610.
67. Jahn O., et al. Myelin proteomics: molecular anatomy of an insulating sheath. Mol. Neurobiol. 2009, 40:55-72.
68. Reiss D.S., et al. Is Na 1K ATPase a myelin-associated enzyme?. J. Neurochem. 1981, 36:1418-1426.
69. Vorbrodt A.W., et al. Cytochemical localization of ouabain-sensitive, K+-dependent p-nitro-phenylphosphatase (transport ATPase) in the mouse central and peripheral nervous systems. Brain Res. 1982, 243:225-234.
70. Mrsulja B.J., et al. Ultracytochemical localization of ouabain-sensitive K+-dependent, p-nitrophenyl phosphatase in myelin. Brain Res. 1985, 343:154-158.
71. Dolapchieva S. Ultracytochemical localization of ouabain-sensitive K(+)-dependent paranitrophenylphosphatase in rat sciatic nerve fibers. Eur. J. Morphol. 1995, 33:247-255.
72. Milner R.J., et al. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell 1985, 42:931-939.
73. Garbern J.Y. Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis. Cell. Mol. Life Sci. 2007, 64:50-65.
74. Helynck G., et al. Brain proteolipids. Isolation, purification and effect on ionic permeability of membranes. Eur. J. Biochem. 1983, 133:689-695.
75. Cherksey B., et al. In vitro analysis of ion channels in periaxolemmal-myelin and white matter clathrin coated vesicles: modulation by calcium and GTP gamma S. Neurochem. Res. 1994, 19:1101-1106.
76. Sapirstein V.S., et al. Isolation and characterization of periaxolemmal and axolemmal enriched membrane fractions from the rat central nervous system. J. Neurosci. Res. 1992, 32:593-604.
77. Regueiro P., et al. Preparation of giant myelin vesicles and proteoliposomes to register ionic channels. J. Neurochem. 1996, 67:2146-2154.
78. Tosteson M.T., Sapirstein V.S. Protein interactions with lipid bilayers: the channels of kidney plasma membrane proteolipids. J. Membr. Biol. 1981, 63:77-84.
79. Fischer I., Sapirstein V.S. Molecular cloning of plasmolipin. Characterization of a novel proteolipid restricted to brain and kidney. J. Biol. Chem. 1994, 269:24912-24919.
80. Fischer I., et al. Plasmolipin: the other myelin proteolipid. A review of studies on its structure, expression, and function. Neurochem. Res. 1994, 19:959-966.
81. Enyedi P., Czirjak G. Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol. Rev. 2010, 90:559-605.
82. Steffensen I., et al. Immunohistochemical localization of the Na+-Ca2+ exchanger in rat central and peripheral myelinated axons. Brain Res. 1997, 776:1-9.
83. Philipson K.D., Nicoll D.A. Sodium-calcium exchange: a molecular perspective. Annu. Rev. Physiol. 2000, 62:111-133.
84. Felts P.A., Smith K.J. Changes in the distribution of a calcium-dependent ATPase during demyelination and remyelination in the central nervous system. J. Neurocytol. 1996, 25:171-180.
85. Mata M., Fink D.J. Ca2+-ATPase in the central nervous system: an EM cytochemical study. J. Histochem. Cytochem. 1989, 37:971-980.
86. Maxwell W.L., et al. Cytochemical evidence for redistribution of membrane pump calcium-ATPase and ecto-Ca-ATPase activity, and calcium influx in myelinated nerve fibres of the optic nerve after stretch injury. J. Neurocytol. 1995, 24:925-942.
87. Hildebrand C., Mohseni S. The structure of myelinated axons in the CNS. Multiple Sclerosis as a Neuronal Disease 2005, 1-28. Elsevier Academic Press. S.G. Waxman (Ed.).
88. Bengtsson S.L., et al. Extensive piano practicing has regionally specific effects on white matter development. Nat. Neurosci. 2005, 8:1148-1150.
89. Paus T., et al. Structural maturation of neural pathways in children and adolescents: in vivo study. Science 1999, 283:1908-1911.
90. Scholz J., et al. Training induces changes in white-matter architecture. Nat. Neurosci. 2009, 12:1370-1371.
91. Wender R., et al. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J. Neurosci. 2000, 20:6804-7610.
92. Brown A.M., et al. Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter. J. Neurosci. Res. 2005, 79:74-80.
93. Brown A.M., et al. Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem. Int. 2004, 45:529-536.
94. Yu S., Ding W.G. The 45 kDa form of glucose transporter 1 (GLUT1) is localized in oligodendrocyte and astrocyte but not in microglia in the rat brain. Brain Res. 1998, 797:65-72.
95. Rinholm J.E., et al. Regulation of oligodendrocyte development and myelination by glucose and lactate. J. Neurosci. 2011, 31:538-548.
96. Kamasawa N., et al. Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: implications for ionic homeostasis and potassium siphoning. Neuroscience 2005, 136:65-86.
97. Orthmann-Murphy J.L., et al. Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. J. Neurosci. 2007, 27:13949-13957.
98. Kleopa K.A., et al. Gap junction disorders of myelinating cells. Rev. Neurosci. 2010, 21:397-419.
99. Nave K.A. Myelination and the trophic support of long axons. Nat. Rev. Neurosci. 2010, 11:275-283.
100. Giuditta A., et al. Local gene expression in axons and nerve endings: the glia-neuron unit. Physiol. Rev. 2008, 88:515-555.
101. Twiss J.L., Fainzilber M. Ribosomes in axons: scrounging from the neighbors?. Trends Cell Biol. 2009, 19:236-243.
102. Court F.A., et al. Schwann cell to axon transfer of ribosomes: toward a novel understanding of the role of glia in the nervous system. J. Neurosci. 2008, 28:11024-11029.
103. Willis D.E., Twiss J.L. Profiling axonal mRNA transport. Methods Mol. Biol. 2011, 714:335-352.
104. McIntosh A.M., et al. White matter tractography in bipolar disorder and schizophrenia. Biol. Psychiatry 2008, 64:1088-1092.
105. Peters B.D., et al. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned?. J. Psychiatr. Res. 2010, 44:993-1004.
106. Chance S.A., et al. Fiber content of the fornix in schizophrenia: lack of evidence for a primary limbic encephalopathy. Am. J. Psychiatry 1999, 156:1720-1724.
107. Uranova N., et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 2001, 55:597-610.
108. Whitford T.J., et al. Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. Schizophr. Bull. 2010, 10.1093/schbul/sbq105.
109. Yamazaki Y., et al. Oligodendrocytes: facilitating axonal conduction by more than myelination. Neuroscientist 2010, 16:11-18.
110. Yamazaki Y., et al. Modulatory effects of oligodendrocytes on the conduction velocity of action potentials along axons in the alveus of the rat hippocampal CA1 region. Neuron Glia Biol. 2007, 3:325-334.
111. Banerjee A., et al. Neuregulin 1-erbB4 pathway in schizophrenia: from genes to an interactome. Brain Res. Bull. 2010, 83:132-139.
112. Heng S., et al. White matter abnormalities in bipolar disorder: insights from diffusion tensor imaging studies. J. Neural Transm. 2010, 117:639-654.
113. White T., et al. Diffusion tensor imaging in psychiatric disorders. Top. Magn. Reson. Imaging 2008, 19:97-109.